Valuation Finch Therapeutics Group, Inc.

Stocks

Market Closed - OTC Markets Other stock markets 12:12:23 2026-07-09 EDT			5-day change	1st Jan Change
10.55 ^USD	+0.29%		+0.48%	-21.78%

04-26	Acurx Pharmaceuticals, Inc., Adiso Therapeutics, Inc., Summit Therapeutics Inc., Finch Therapeutics Group, Inc. and Astrazeneca plc Announces Clostridium Difficile Infections Clinical Trial Updates	CI
03-26	Motion for Joint Administration Approved for Finch Therapeutics Group, Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	473.4	22.99	5.797
Change	-	-95.14%	-74.79%
Enterprise Value (EV) ¹	345.9	4.311	10.8
Change	-	-98.75%	150.5%
P/E	-6.72x	-0.2x	-0.08x
PBR	2.34x	0.24x	0.25x
PEG	0.1x	-0x	0x
Capitalization / Revenue	25.5x	26.7x	54.2x
EV / Revenue	18.7x	5.01x	101x
EV / EBITDA	-6x	-0.05x	-0.33x
EV / EBIT	-5.77x	-0.05x	-0.32x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-44.51	-72.12	-46.59
Distribution rate	-	-	-
Net sales ¹	18.53	0.861	0.107
EBITDA ¹	-57.68	-89.61	-32.48
EBIT ¹	-59.98	-95.12	-34
Net income ¹	-58.16	-114.6	-74.75
Net Debt ¹	-127.4	-18.68	5.002
Reference price ²	299.10	14.40	3.61
Nbr of stocks (in thousands)	1,583	1,597	1,606
Announcement Date	3/31/22	3/23/23	3/25/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FINCH THERAPEUTICS GROUP, INC.	-	-	-	-	16.94M
LONZA GROUP AG	35.38x	6.18x	19.12x	0.93%	50.73B
REVOLUTION MEDICINES, INC.	-23.4x	342.07x	-22.1x	-.--%	39.73B
IQVIA HOLDINGS INC.	25.29x	2.8x	12.09x	-.--%	34.69B
BEONE MEDICINES AG	45.73x	4.51x	28.9x	-.--%	33.21B
CELLTRION, INC.	27.05x	7.93x	19.91x	0.42%	26.76B
MEDPACE HOLDINGS, INC.	31.75x	5.12x	23.32x	-.--%	15.37B
EUROFINS SCIENTIFIC SE	23.95x	2.04x	8.96x	1.12%	13.78B
ICON PUBLIC LIMITED COMPANY	23.74x	1.89x	11.45x	-.--%	12.85B
Average	23.69x	46.57x	12.71x	0.31%	25.24B
Weighted average by Cap.	22.49x	63.82x	11.59x	0.32%